Camber Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-525,000
| Closed | -$11.6M | – | 41 |
|
|
2020
Q4 | $11.6M | Hold |
525,000
| – | – | 0.41% | 26 |
|
|
2020
Q3 | $9.45M | Buy |
+525,000
| New | +$9.45M | 0.5% | 30 |
|
|
2018
Q2 | – | Sell |
-1,000,000
| Closed | -$9.56M | – | 36 |
|
|
2018
Q1 | $9.56M | Hold |
1,000,000
| – | – | 0.47% | 29 |
|
|
2017
Q4 | $9.03M | Buy |
+1,000,000
| New | +$9.03M | 0.44% | 27 |
|